Brief: Disc Presents Initial Positive Data From Ongoing Phase 1B/2 Trial Of Disc-0974 In Patients With Myelofibrosis (MF) And Anemia

Disc Medicine

11/12/2023 17:04

Dec 11 (Reuters) - Disc Medicine Inc  IRON.O :
    * DISC PRESENTS INITIAL POSITIVE DATA FROM ONGOING PHASE
1B/2
TRIAL OF DISC-0974 IN PATIENTS WITH MYELOFIBROSIS (MF) AND
ANEMIA AT THE 65TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL
MEETING
    * DISC MEDICINE INC - SUBSTANTIAL, DOSE-DEPENDENT REDUCTIONS
IN
SERUM HEPCIDIN AND INCREASES IN SERUM IRON
    * DISC MEDICINE INC - HEMATOLOGIC RESPONSE DEMONSTRATED BY
INCREASED HEMOGLOBIN LEVELS AND REDUCTION IN TRANSFUSION BURDEN
    * DISC MEDICINE INC - DISC-0974 WAS GENERALLY WELL-TOLERATED
AT
ALL EVALUATED DOSES

Source text for Eikon:  ID:nGNX4B5rs7 
Further company coverage:  IRON.O 

 ((Reuters.Briefs@thomsonreuters.com;))